منبع: MarketBeat
خبرگزاری
سهام
اهمیت متوسط
Eli Lilly and Company Q2 Earnings Call Highlights
Eli Lilly and Company NYSE: LLY reported 48% revenue growth in the second quarter of 2026, driven primarily by continued demand for its cardiometabolic medicines MOUNJARO and ZEPBOUND, while raising its full-year revenue and earnings guidance.
نمادهای مرتبط
1
L
LLY
LLY
منبع: MarketBeat
مشاهده منبع